Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied DNA Sciences, Inc. - Common Stock (NQ: APDN )

0.0531 -0.0104 (-16.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,824,874
Open 0.0620
Bid (Size) 0.0550 (1,358)
Ask (Size) 0.0565 (50)
Prev. Close 0.0635
Today's Range 0.0507 - 0.0645
52wk Range 0.0507 - 11.76
Shares Outstanding 54,111,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Wednesday's session
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
Which stocks are experiencing notable movement on Wednesday?
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill

Performance

YTD
-78.50%
-78.50%
1 Month
-68.82%
-68.82%
3 Month
-75.30%
-75.30%
6 Month
-96.48%
-96.48%
1 Year
-99.50%
-99.50%

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
Via ACCESS Newswire
Earnings Scheduled For February 13, 2025
Via Benzinga
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
Via ACCESS Newswire
Get insights into the top gainers and losers of Wednesday's pre-market session.
Via Chartmill
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
Via ACCESS Newswire
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
Via ACCESS Newswire
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
Via ACCESSWIRE
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Via ACCESSWIRE
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
Via ACCESSWIRE
US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Via ACCESSWIRE
Earnings Scheduled For December 17, 2024
Via Benzinga
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
Via ACCESSWIRE
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
Via Benzinga
Exposures Fossil Fuels
S&P 500 Edges Lower; US Crude Oil Inventories Fall
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Surges Over 150 Points; Alphabet Posts Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Applied DNA Sciences (APDN) Stock Is Down 37% Today
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.